XARELTO
BAYER INC
Quick answers
Is there a shortage of XARELTO in Canada?
No. There is no current shortage of XARELTO 103.4MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
XARELTO
BAYER INC
REDDY-RIVAROXABAN
DR REDDY'S LABORATORIES LTD
APO-RIVAROXABAN
APOTEX INC
AG-RIVAROXABAN
ANGITA PHARMA INC.
BIO-RIVAROXABAN
BIOMED PHARMA
TARO-RIVAROXABAN
TARO PHARMACEUTICALS INC
DIN
02510170
Strength
103.4MG
Dosage Form
GRANULES FOR SUSPENSION
Route
ORAL
Compare with another product →
Product Monograph
Product monograph is not available from Health Canada
Shortage History
Other (Please describe in comments)
Demand increase for the drug.
Other Products from BAYER INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
60MG · DIN 02155990
20MG · DIN 02237618
30MG · DIN 02155907
2.5MG · DIN 02412810
1MG · DIN 02412772
0.5MG · DIN 02412764
2MG · DIN 02412802
1.5MG · DIN 02412799
5MG · DIN 02243919
0.5MG · DIN 02247193
DIN 02309300
220MG · DIN 02436337